Michael Heuser

30k citations
392 papers · 22.8k · 10 hit papers · h-index 71

Impact in

  • Hematology top 0.02%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 1%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Acute Myeloid Leukemia Research 307
    • Hematopoietic Stem Cell Transplantation 23
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 16

Michael Heuser

376 papers receiving 22.5k citations

Michael Heuser's Hit Papers

Ivosidenib and Azacitidine in IDH1 -Mutated Acute Myeloid Leukemia 2022 · 380 citations
3800+3+6Years since publication1k2k3k

Peers

Michael Heuser
Comparison fields: 5 of 126
  • Hematology 15.2k
  • Genetics 999
  • Cancer Research 1.1k
  • Cardiology and Cardiovascular Medicine 1.8k
  • Oncology 1.4k
Replace Ravi Vij with:
Ravi Vij United States
A. Keith Stewart United States
Xavier P Leleu France
Michael L. Wang United States
Martin H. Dreyling Germany
Harry Paul Erba United States
Norbert Gattermann Germany
Richard F. Schlenk Germany
RONALD L. PAQUETTE United States
Courtney Denton Dinardo United States
Michael Heuser relative to Ravi Vij United States Ravi Vij's profile →
Citations per field
00.5×2×4×6.7×
Ravi Vij · 1×
Citations per year

Countries citing papers authored by Michael Heuser

Since Specialization
Citations

This map shows the geographic impact of Michael Heuser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Heuser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Heuser more than expected).

Fields of papers citing papers by Michael Heuser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Heuser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Heuser. The network helps show where Michael Heuser may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Heuser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Heuser Line = papers co-authored together Michael Heuser links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 392 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Hit paper breakdown →
20163373
2
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Hit paper breakdown →
20221918
3
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
Hit paper breakdown →
2018847
4
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
Hit paper breakdown →
2022588
5
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
Hit paper breakdown →
2021552
6
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Hit paper breakdown →
2020510
7
Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
Hit paper breakdown →
2018400
8
Ivosidenib and Azacitidine in IDH1 -Mutated Acute Myeloid Leukemia
Hit paper breakdown →
2022380
9 2012369
10
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Hit paper breakdown →
2022347
11 2011330
12 2011253
13 2018247
14 2015245
15 2018244
16
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS
Hit paper breakdown →
2020244
17 2017224
18 2017223
19 2016218
20 2010213

About Michael Heuser

Michael Heuser is a scholar working on Hematology, Genetics, Oncology, Cancer Research and Molecular Biology, having authored 392 papers that have together received 22.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (307 papers), Hematopoietic Stem Cell Transplantation (23 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), MicroRNA in disease regulation (10 papers), CAR-T cell therapy research (9 papers), Acute Lymphoblastic Leukemia research (7 papers), RNA Interference and Gene Delivery (6 papers) and Retinoids in leukemia and cellular processes (5 papers). The work is most often cited by research in Hematology (15.2k citations), Genetics (999 citations), Cancer Research (1.1k citations), Cardiology and Cardiovascular Medicine (1.8k citations) and Oncology (1.4k citations). Michael Heuser has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Arnold Ganser, Felicitas R. Thol, Brigitte Schlegelberger, Gudrun Göhring, Frédérik Damm, Jürgen Krauter, Walter Fiedler, Katharina Wagner, Richard F. Schlenk and Oliver Gerhard Ottmann. Their work appears in journals such as Blood, Leukemia, Annals of Hematology, Haematologica and HemaSphere.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact